Publications by authors named "David Berenbeim"

Claim this Profile
F
Formulary implications of management of pulmonary arterial Hypertension: Part II--Payer and provider perspectives on new therapeutic options.
Jeremy Feldman, David Berenbeim

Manag Care Interface· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulary implications of management of pulmonary arterial hypertension: Part I--An overview of existing and new pharmacological treatment options.
Jeremy Feldman, David Berenbeim

Manag Care Interface· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of switching on compliance and persistence: the case of statin treatment.
Patrick Thiebaud, Bimal V Patel, Michael B Nichol, David M Berenbeim

Am J Manag Care· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incretin mimetics: promising new therapeutic options in the treatment of type 2 diabetes.
Jeremy M Gleeson, David M Berenbeim, Robert J Gilkin

J Manag Care Pharm· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The medical group pay-for-performance initiative in California and diabetes care.
David Berenbeim

Manag Care Interface· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of an over-the-counter migraine medication program on quality of life.
Caroline T Burk, Alex Gilderman, Joyce Salas, David Berenbeim, Michael B Nichol

Headache· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polypharmacy: overdosing on good intentions.
David M Berenbeim

Manag Care Q· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis